Remote Patient Monitoring (RPM) programs generate a steady flow of physiologic data between office visits, and that volume grows every time a device or a patient is added to a panel. Care teams reviewing readings from blood pressure cuffs, glucometers, and pulse oximeters can face hundreds of data points in a single day, and most fall within a patient’s normal range. AI-powered triage, meaning artificial intelligence (AI) software that sorts and scores incoming readings, is one approach healthcare organizations are using to manage this pattern. Rather than presenting every reading in the order it arrived, the software surfaces the readings most likely to need clinical attention first. This article looks at how AI-powered triage works inside RPM programs, what the current evidence and federal guidance say about it, and what healthcare organizations should ask before adopting it.
Important Distinction
AI-powered triage sorts and scores data. It does not diagnose, prescribe, or make a treatment decision. A clinician or care team member reviews every flagged reading, and the review record documents who made that decision and when.
How AI-Powered Triage Works in RPM Programs
AI-powered triage uses machine learning models to evaluate incoming patient data, identify patterns, and route the readings that appear most likely to need review to the top of a care team’s queue. Unlike a fixed alert threshold, which flags a reading the moment it crosses a set number, a machine learning model can weigh a reading against a patient’s own baseline as well as general clinical ranges.
- Data ingestion from connected RPM devices and, where integrated, the patient’s Electronic Health Record (EHR).
- Pattern analysis, in which a machine learning model compares new readings against a patient’s baseline and general clinical thresholds.
- Risk scoring, which ranks readings by how closely they match patterns associated with clinical concern.
- Routing to a care team queue, so higher-scored readings appear first for review by a nurse, care coordinator, or physician.
The output is a sorted queue, not a diagnosis. A clinician still reviews the flagged reading and decides what happens next.
Why Alert Volume Is a Growing Concern
Non-actionable alerts are a documented problem in monitored care settings, not just a theoretical one. Research dating back more than a decade has found that a large share of alerts generated by physiologic monitors do not require a clinical response, though the exact share varies by study and by care setting. A 2026 systematic review examined 31 studies published between 2015 and 2025 that used artificial intelligence to reduce false or non-actionable alerts.[3] The review found that random forest was the most common machine learning approach and that convolutional neural networks (CNNs) were the most common neural network approach, typically applied to arrhythmia and vital-sign threshold alerts.[3] The review’s authors also found that many of the included studies lacked external validation and relied on small sample sizes, meaning results measured on one dataset did not always hold up when a model was later tested against data from a different patient population.[3]
Key Insight
Published performance numbers describe how a model performed on its own test data. They do not ensure the same performance once a tool is deployed across a different patient population, which is why asking about external validation matters as much as asking about the headline result.
This is a useful caution for healthcare organizations evaluating AI triage tools. Organizations considering AI triage should ask a vendor how a model was validated and whether that validation included data from outside the original training set.
How AI Triage Supports Care Teams
Sorting Alerts by Clinical Relevance
Rather than presenting every reading in arrival order, a triage model sorts a queue so the readings that most resemble a clinically relevant pattern reach a reviewer first. This does not eliminate alerts. It changes the order a care team sees them in.
Supporting Earlier Review of Changing Trends
Because a model can weigh a series of readings over time rather than a single point-in-time value, it can flag a gradual trend, such as a slow rise in blood pressure over several weeks, that a single threshold alert might not catch. Flagging a trend earlier gives a clinician more time to review the case, which may help reduce the risk of an avoidable hospitalization.
Helping Care Teams Manage Larger Patient Panels
Sorting readings by relevance can help a nurse or care coordinator work through a larger panel of monitored patients in a given day, since fewer readings need a full manual review before a decision is made about whether follow-up is needed.
Improving as More Data Is Collected
A machine learning model is typically retrained on a set schedule as new outcome data becomes available, which can improve how well it distinguishes readings that need review from readings that do not. Any update to a model that is part of certified health IT or an FDA-authorized device is subject to its own review and documentation requirements.[1][2]
Where AI Triage Fits in the Clinical Workflow
AI triage typically runs inside an RPM dashboard or connects to an EHR rather than operating as a separate system. In practice, that usually looks like:
- Automated queue sorting: higher-scored readings appear first in a care team’s review queue, while lower-scored readings remain available for review on the same schedule.
- Task routing: readings can be routed to a nurse, care coordinator, or physician based on the type of reading and the practice’s own protocols.
- Trend visualization: real-time dashboards display a patient’s readings over time alongside the current score, so a reviewer sees the pattern behind a flagged reading rather than a single number.
AI Triage and Value-Based Care Programs
Sorting patient data by relevance connects to a broader shift in how Medicare and other payers evaluate chronic care programs: several current and developing payment models base part of reimbursement on documented patient outcomes rather than only on the services delivered. Supporting earlier review of changing patient data is one way an RPM program can work toward the outcome measures those programs track, though the connection between any specific triage tool and a specific payment outcome has not been independently established and should not be assumed.
Data Privacy, Security, and Regulatory Considerations
AI triage systems process Protected Health Information (PHI), so they fall under the same compliance requirements as any other health technology handling patient data. Organizations should confirm that a triage tool meets Health Insurance Portability and Accountability Act (HIPAA) requirements and follows the security standards described in the Health Information Technology for Economic and Clinical Health (HITECH) Act, including encryption in transit and at rest, access controls limited to authorized users, and audit logging of who reviewed which reading and when.
Federal oversight of AI in health technology has expanded in recent years. As of January 1, 2025, the decision support intervention (DSI) certification criterion adopted under the Office of the National Coordinator for Health Information Technology’s (ONC) HTI-1 final rule became part of the definition of a Base EHR. Developers that supply a predictive DSI, meaning software that uses an algorithm or model to produce a prediction, classification, recommendation, or risk score, must provide structured information about how that tool was built and validated, referred to as source attributes.[2] Practices using an EHR with AI-based triage features can ask their EHR vendor whether that feature is documented as a predictive DSI and what source attributes are available for review.
Separately, the U.S. Food and Drug Administration (FDA) maintains a public list of AI-enabled medical devices that have been cleared, granted a De Novo request, or approved for marketing in the United States. The list has grown to more than 1,500 devices as of 2026, most of them in radiology.[1] In August 2025, the FDA finalized guidance on Predetermined Change Control Plans (PCCPs), which allow a manufacturer to describe planned future updates to an AI-enabled device’s model in advance, subject to FDA review, rather than filing a new submission for every update. Healthcare organizations evaluating an AI-enabled RPM device can ask whether it appears on the FDA’s list and, if so, whether it includes a PCCP describing how future updates will be handled.
Addressing Implementation Challenges
Adopting AI triage involves a few practical considerations beyond the technology itself:
- Training: care teams need to understand what a triage score does and does not mean before they rely on it, since a score is an input to clinical judgment, not a replacement for it.
- Interoperability: a triage tool needs to connect with a practice’s existing RPM devices and EHR without disrupting established workflows.
- Explainability: reviewers should be able to see why a reading was scored the way it was, not only the resulting score, particularly given the ONC transparency requirements described above.
How DrKumo Supports Data-Driven RPM Programs
DrKumo’s Remote Patient Monitoring (RPM) technology organizes physiologic data from connected devices into a structured view for care teams managing patients with chronic conditions, including those served by Federally Qualified Health Centers (FQHCs) and Rural Health Clinics (RHCs). The platform works alongside DrKumo’s evidence-based Disease Management Protocols (DMPs) for hypertension, diabetes, heart failure, and Chronic Obstructive Pulmonary Disease (COPD), so readings are reviewed within a structured, provider-directed protocol rather than in isolation. DrKumo’s infrastructure follows HIPAA and FIPS-compliant cybersecurity practices, consistent with the compliance considerations described above.
DrKumo is a technology provider only and does not provide clinical services. Providers retain full clinical responsibility for interpreting patient data, exercising clinical judgment, and making treatment decisions. DrKumo supports care teams by organizing data for review; it does not replace a clinician’s evaluation, and Remote Patient Monitoring (RPM) does not replace emergency care.
Key Takeaways
AI-powered triage sorts and scores incoming RPM data so a care team can review the readings most likely to need attention first. It changes the order data is reviewed in; it does not replace the clinician’s review of that data or the decisions that follow.
Current evidence on AI methods for reducing alert volume is promising but not conclusive. A 2026 systematic review of 31 studies found that many lacked external validation, so results can vary by implementation and by patient population. Organizations should ask vendors how a model was validated before relying on its output.
Federal oversight of AI in health technology has expanded, including ONC’s transparency requirements for predictive decision support tools in certified EHRs (effective January 1, 2025) and FDA’s growing AI-Enabled Medical Device List. DrKumo is a technology provider only, not a clinical entity, and does not make treatment decisions on a provider’s behalf.
Structured Data, Clearer Review
See how DrKumo organizes RPM data so your care team can focus on what needs review.
To learn how DrKumo can help your organization deliver secure, HIPAA-compliant remote patient monitoring with structured data review, contact us today. Our team is ready to support your journey toward better patient care.
Frequently Asked Questions
Common questions about AI-powered triage in Remote Patient Monitoring programs.
What is AI-powered triage in Remote Patient Monitoring?
AI-powered triage is software that uses machine learning to sort and score incoming RPM readings so the readings most likely to need clinical attention are reviewed first, rather than reviewing every reading in the order it arrived.
Does AI triage replace a clinician’s review of patient data?
No. AI triage changes the order in which data is reviewed. A clinician or care team member still reviews the flagged reading and makes the clinical decision.
How is AI triage different from a standard alert threshold?
A standard threshold flags a reading the moment it crosses a fixed number. An AI triage model can also weigh a reading against a patient’s own baseline and against patterns in past readings, which may catch a gradual trend that a single threshold would miss.
What regulations apply to AI used in RPM and EHR systems?
AI features built into certified EHRs are subject to ONC’s HTI-1 transparency requirements for decision support interventions, effective January 1, 2025. AI-enabled medical devices are separately subject to FDA review and appear on FDA’s public AI-Enabled Medical Device List.
Can AI triage reduce false or non-actionable alerts?
Research suggests it can. A 2026 systematic review of 31 studies found AI and machine learning approaches showed promise for reducing false alerts, though many of the studies reviewed lacked external validation, so results vary by implementation.
Does DrKumo use AI to triage RPM data?
DrKumo’s platform organizes RPM data for care team review as part of its broader remote monitoring and Disease Management Protocol offerings. DrKumo is a technology provider only and does not make clinical decisions; providers retain full clinical responsibility for patient care.
References
U.S. Food and Drug Administration. (2026). Artificial Intelligence-Enabled Medical Devices. FDA.gov.
Office of the National Coordinator for Health Information Technology. (2024). HTI-1 Final Rule. HealthIT.gov.
Kosonen, M. (2026). Artificial Intelligence for Reducing Alarm Fatigue in Hospitals: A Systematic Review. In Digital Health and Wireless Solutions: Integrating AI, LLMs and Multimodal Health Data for Next-Generation Decision Support. Springer.
Disclaimer: This article is intended for informational purposes only and does not constitute medical, legal, or compliance advice. Remote Patient Monitoring (RPM) is intended for monitoring purposes only and does not replace emergency care or in-person clinical evaluation; always consult a licensed healthcare provider for guidance on diagnosis, treatment, or medical decisions. Regulatory guidance, device authorizations, and research findings referenced in this article are subject to change; readers should confirm current requirements directly with CMS.gov, FDA.gov, HealthIT.gov, or a qualified compliance professional before making implementation decisions. DrKumo is a technology provider and is not a clinical entity; it does not provide clinical services or make treatment decisions.
